Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0000950170-24-002502 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-05 | 2024-01-03 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $29.50 | -4,608 | 40.8K | -10% | -$136.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-03 | S | D | 307 | $30.12 | 45,146 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-03 | S | D | 4,301 | $29.46 | 40,845 | D | — | — |